Comparison of Pilocarpine, Brimonidine, Oxymetazoline, Hialuronic Acid, Bromfenac Ophthalmic Compound With Pilocarpine and Brimonidine to Improve Uncorrected Visual Acuity in Healthy Presbyopic Individuals
Latest Information Update: 04 Aug 2023
At a glance
- Drugs Brimonidine (Primary) ; Bromfenac (Primary) ; Hyaluronic acid (Primary) ; Oxymetazoline (Primary) ; Pilocarpine (Primary)
- Indications Presbyopia
- Focus Therapeutic Use
- Acronyms PBOHB
- 19 Aug 2021 New trial record
- 14 Aug 2021 Planned End Date changed from 1 Sep 2021 to 10 Sep 2021.
- 14 Aug 2021 Planned primary completion date changed from 1 Sep 2021 to 30 Aug 2021.